We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
National targeted lung cancer screening programme designed to catch cancer sooner announced.
One-year and 3-year case-mix adjusted percentage of cancers diagnosed at stages 1 and 2, as compared to stages 1 to 4, by Clinical Commissioning Group for 21 cancer groups.
The Routes to Diagnosis project links multiple health datasets to categorise the pathways that lead to a patient’s diagnosis of cancer.
Information on the waiting times of patients with suspected cancer and those subsequently diagnosed with cancer.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (6 March 2024) approved the medicine piflufolastat (18F) (Pylclari) as a diagnostic tool for people with suspected or known prostate cancer.
Survival for people diagnosed by cancer type, split by stage at diagnosis. Data based on people diagnosed in England in 2012, 2013 and 2014.
Chief Medical Officer for England, Professor Chris Whitty's annual reports and lectures on medicine and public health.
This document provides best practice advice on passing on the results of a case audit to the individual concerned.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.